160 related articles for article (PubMed ID: 11476126)
1. Fluoxetine in the prevention of depressive recurrences: a double-blind study.
Gilaberte I; Montejo AL; de la Gandara J; Perez-Sola V; Bernardo M; Massana J; Martin-Santos R; Santiso A; Noguera R; Casais L; Perez-Camo V; Arias M; Judge R;
J Clin Psychopharmacol; 2001 Aug; 21(4):417-24. PubMed ID: 11476126
[TBL] [Abstract][Full Text] [Related]
2. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
Keller MB; Trivedi MH; Thase ME; Shelton RC; Kornstein SG; Nemeroff CB; Friedman ES; Gelenberg AJ; Kocsis JH; Dunner DL; Hirschfeld RM; Rothschild AJ; Ferguson JM; Schatzberg AF; Zajecka JM; Pedersen RD; Yan B; Ahmed S; Musgnung J; Ninan PT
J Clin Psychiatry; 2007 Aug; 68(8):1246-56. PubMed ID: 17854250
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of fluoxetine in treating bipolar II major depressive episode.
Amsterdam JD; Garcia-España F; Fawcett J; Quitkin FM; Reimherr FW; Rosenbaum JF; Schweizer E; Beasley C
J Clin Psychopharmacol; 1998 Dec; 18(6):435-40. PubMed ID: 9864074
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder.
Schmidt ME; Fava M; Robinson JM; Judge R
J Clin Psychiatry; 2000 Nov; 61(11):851-7. PubMed ID: 11105738
[TBL] [Abstract][Full Text] [Related]
5. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study.
Amsterdam JD; Shults J
Am J Psychiatry; 2010 Jul; 167(7):792-800. PubMed ID: 20360317
[TBL] [Abstract][Full Text] [Related]
7. Fluoxetine versus amitriptyline in the treatment of major depression with associated anxiety (anxious depression): a double-blind comparison.
Versiani M; Ontiveros A; Mazzotti G; Ospina J; Dávila J; Mata S; Pacheco A; Plewes J; Tamura R; Palacios M
Int Clin Psychopharmacol; 1999 Nov; 14(6):321-7. PubMed ID: 10565798
[TBL] [Abstract][Full Text] [Related]
8. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ
J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: a meta-analysis of the 20-mg/day dose.
Beasley CM; Nilsson ME; Koke SC; Gonzales JS
J Clin Psychiatry; 2000 Oct; 61(10):722-8. PubMed ID: 11078032
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
[TBL] [Abstract][Full Text] [Related]
11. Moclobemide versus fluoxetine for double depression: a randomized double-blind study.
Duarte A; Mikkelsen H; Delini-Stula A
J Psychiatr Res; 1996; 30(6):453-8. PubMed ID: 9023788
[TBL] [Abstract][Full Text] [Related]
12. Lack of efficacy of fluoxetine in recurrent brief depression and suicidal attempts.
Montgomery DB; Roberts A; Green M; Bullock T; Baldwin D; Montgomery SA
Eur Arch Psychiatry Clin Neurosci; 1994; 244(4):211-5. PubMed ID: 7888419
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment of obsessive-compulsive disorder after an acute response: a comparison of fluoxetine versus placebo.
Romano S; Goodman W; Tamura R; Gonzales J
J Clin Psychopharmacol; 2001 Feb; 21(1):46-52. PubMed ID: 11199947
[TBL] [Abstract][Full Text] [Related]
14. Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline.
Marchesi C; Ceccherininelli A; Rossi A; Maggini C
Pharmacopsychiatry; 1998 Nov; 31(6):216-21. PubMed ID: 9930635
[TBL] [Abstract][Full Text] [Related]
15. Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety.
De Nayer A; Geerts S; Ruelens L; Schittecatte M; De Bleeker E; Van Eeckhoutte I; Evrard JL; Linkowski P; Fossion P; Leyman S; Mignon A
Int J Neuropsychopharmacol; 2002 Jun; 5(2):115-20. PubMed ID: 12135535
[TBL] [Abstract][Full Text] [Related]
16. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
[TBL] [Abstract][Full Text] [Related]
17. Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: results from the PREVENT study.
Thase ME; Gelenberg A; Kornstein SG; Kocsis JH; Trivedi MH; Ninan P; Li T; Pedersen R; Keller M
J Psychiatr Res; 2011 Mar; 45(3):412-20. PubMed ID: 20801464
[TBL] [Abstract][Full Text] [Related]
18. Escitalopram continuation treatment prevents relapse of depressive episodes.
Rapaport MH; Bose A; Zheng H
J Clin Psychiatry; 2004 Jan; 65(1):44-9. PubMed ID: 14744167
[TBL] [Abstract][Full Text] [Related]
19. Clinical response predictors in a double-blind, placebo-controlled trial of fluoxetine for geriatric major depression. Fluoxetine Collaborative Study Group.
Small GW; Hamilton SH; Bystritsky A; Meyers BS; Nemeroff CB
Int Psychogeriatr; 1995; 7 Suppl():41-53. PubMed ID: 8580391
[TBL] [Abstract][Full Text] [Related]
20. Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: an updated meta-analysis.
Beasley CM; Koke SC; Nilsson ME; Gonzales JS
Clin Ther; 2000 Nov; 22(11):1319-30. PubMed ID: 11117656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]